Literature DB >> 16564944

Understanding the basic case-mix adjustment for the composite rate.

John R C Wheeler1, Joseph M Messana, Marc N Turenne, Richard A Hirth, Alyssa S Pozniak, Qing Pan, Chien-Chia Chuang, Kathryn Slish, Philip Tedeschi, Erik C Roys, Robert A Wolfe.   

Abstract

In April 2005, Medicare began adjusting payments to dialysis providers for composite-rate services for a limited set of patient characteristics, including age, body surface area, and low body mass index. We present analyses intended to help the end-stage renal disease community understand the empirical reasons behind the new composite-rate basic case-mix adjustment. The U-shaped relationship between age and composite-rate cost that is reflected in the basic case-mix adjustment has generated significant discussion within the end-stage renal disease community. Whereas greater costs among older patients are consistent with conventional wisdom, greater costs among younger patients are caused in part by more skipped sessions and a greater incidence of certain costly comorbidities. Longer treatment times for patients with a greater body surface area combined with the largely fixed cost structure of dialysis facilities explains much of the greater cost for larger patients. The basic case-mix adjustment reflects an initial and partial adjustment for the cost of providing composite-rate services.

Entities:  

Mesh:

Year:  2006        PMID: 16564944     DOI: 10.1053/j.ajkd.2005.12.037

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  2 in total

1.  Provider monitoring and pay-for-performance when multiple providers affect outcomes: An application to renal dialysis.

Authors:  Richard A Hirth; Marc N Turenne; John R C Wheeler; Qing Pan; Yu Ma; Joseph M Messana
Journal:  Health Serv Res       Date:  2009-06-22       Impact factor: 3.402

2.  The organization and financing of kidney dialysis and transplant care in the United States of America.

Authors:  Richard A Hirth
Journal:  Int J Health Care Finance Econ       Date:  2007-12
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.